Welcome : Guest

Eyegate Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Eyegate Pharmaceuticals, Inc., which is principally a Clinical-Stage Specialty Pharmaceutical Company. Illustrated with 14 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-66076
Price: $700
Company Type: Public
Pages: 16
Date: January 2017
Market Data Tables: 14

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
  EYEGATE PHARMACEUTICALS, INC. (USA) (Complete Report)Pages : 16|$ 700.00
1. COMPANY SNIPPETS......1
2. COMPETITION BY DIVISION......2
3. MARKET OVERVIEW......3
Ophthalmic Drugs......3
Table 1: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......3
Table 2: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......4
Glaucoma Drugs......5
Table 3: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......5
Table 4: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......6
Table 5: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......7
Table 6: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......8
Cataract Market......9
Table 7: Visual Impairment Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Cataract, Glaucoma, Uncorr Refrerrors, and Others......9
Table 8: Blindness Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Age-Related Macular Degeneration, Cataract, Glaucoma, and Others......10
Table 9: Cataract Surgeries Market in China (2015-2020) in RMB Million......11
Diabetic Macular Edema (DME) Drugs......12
Table 10: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......12
Table 11: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......13
Wet Age-Related Macular Degeneration (AMD) Anti Vascular Endothelial Growth Factor (VEGF)......14
Table 12: Wet Age-Related Macular Degeneration (AMD) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Avastin, Eylea, and Lucentis......14
4. COMPETITIVE LANDSCAPE......15
Ophthalmology Drugs......15
Table 13: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......15
Table 14: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......16